Pulse 탐색 nav.journalClub 토론 트렌드 연구자

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

홈 탐색 nav.journalClub 트렌드

⌘+K

Latamoxef‐induced coagulation disorders: Incidence and risk factors | Synapse

June 10, 2021

View Full Paper

Latamoxef‐induced coagulation disorders: Incidence and risk factors

YCYan CaiKunming Medical University MZMinggang ZhangBaoji University of Arts and Sciences YWYan WangSecond Affiliated Hospital of Jilin University

Key Points

Key points are not available for this paper at this time.

Abstract

Latamoxef might induce coagulation disorders. Cumulative DDDs and the nutrition risk were linked with coagulation disorders.

AI에게 질문

Like

Bookmark

Share

View Full Paper

AI에게 질문

Like

Bookmark

Share

View Full Paper

Cite This Study

Cai et al. (Thu,) studied this question.

synapsesocial.com/papers/69db668078a3e0e288685272 https://doi.org/https://doi.org/10.1111/jcpt.13435

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Association Between Cephalosporin and Hypoprothrombinemia: A Systematic Review and Meta-Analysis2019 · 37 citations
2Hemorrhagic tendency as a complication of moxalactam therapy in bacterial meningitis1983 · 7 citations
3Effects of various doses of latamoxef (moxalactam) on haemostasis1986 · 10 citations
4Comparative efficacy and safety of ceftizoxime, cefotaxime and latamoxef in the treatment of bacterial pneumonia in high risk patients1987 · 12 citations
5Clinical Risk Factors for Prolonged PT/PTT in Abdominal Sepsis Patients Treated with Moxalactam or Tobramycin Plus Clindamycin1985 · 8 citations